LESI | Print Page | Sign In | Join
Online Store: Webinar Recordings
Main Storefront
        

LES Webinar: Cannabis, Intellectual Property, and Commercialization

Item Options
Sign in for your pricing!
Price: $69.00
Quantity: *
 
Description

LES Webinar: Cannabis, Intellectual Property, and Commercialization

 

The conflicting nature of federal versus state laws regarding the legality of cannabis, both for medical and recreational purposes, can cause complications for those seeking patents, trademarks, or other intellectual property protections, for business growth and expansion, and licensing for their business, IP, or ideas.

This panel will inform the audience of the opportunities and unique challenges the cannabis industry faces trying to develop an intellectual portfolio (including global portfolios), protect and enforce intellectual property rights, grow a cannabis company using IP licensing, and myriad other issues, including the FDA regulations, related to intellectual property and commercialization in the cannabis sector. The panel will also address current trends in IP litigation in the cannabis industry. Lastly, attendees will hear an overview of how IPRs for cannabis are applied in other countries, illustrating the challenges of establishing a strategy for international protection.

CLE: 1.5 hours CLE credit available (California)

 

Members: Free

Non-Members: $69

 

 

 

 

Sponsors

Connect with more than 500 intellectual capital management decision-makers and thought leaders around the world.  Join us at the LES 2025 Annual Meeting as a sponsor to promote your company and discover new business opportunities. Learn more

 

 
401 Edgewater Place, Suite 600, Wakefield, MA 01880
Phone: 703-234-4058

This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.